Mice with FVIII deficiency were given either fitusiran, which reduced AT antigen by 70% in vivo, or 25 U/kg of FVIII, which results in 0.5 U/mL or 50% FVIII levels in vivo. The gene discussed is F8; the disease is hyperinsulinemic hypoglycemia, familial, 4.